For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...